LCZ696 ameliorates lipopolysaccharide-induced endothelial injury

Lipopolysaccharide (LPS)-induced endothelial dysfunction plays an important role in the pathogenesis of cardiovascular diseases. LCZ696, the dual-acting angiotensin receptor blocker, and neprilysin inhibitor has been used for the treatment of heart failure with reduced ejection fraction. Recent work...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Aihong, Wang, Yu, Gao, Xiao, Tian, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064163/
https://www.ncbi.nlm.nih.gov/pubmed/33839697
http://dx.doi.org/10.18632/aging.202692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064163/
https://www.ncbi.nlm.nih.gov/pubmed/33839697
http://dx.doi.org/10.18632/aging.202692

Ejemplares similares